Changes in uptake of vitamin B12 and trace metals in brains of mice treated with clioquinol

Journal of the Neurological Sciences

Volumn 173, Issue 1, 2000, Pages 40-44

  Yassin, M S ^a   Ekblom, J ^a   Xilinas, M ^b   Gottfries, C G ^b   Oreland, L ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Clioquinol; L Methionine S adenosyltransferase (MAT); Methylation; S Adenosylmethionine (SAM); Subacute myelo optic neuropathy (SMON); Vitamin B12

Indexed keywords

CADMIUM; CLIOQUINOL; COBALT; COBALT 57; CYANOCOBALAMIN; IRON; LEAD; MANGANESE; NICKEL; S ADENOSYLMETHIONINE; TRACE METAL; URANIUM; ZINC;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD ANALYSIS; BLOOD BRAIN BARRIER; CONTROLLED STUDY; DRUG DISTRIBUTION; DRUG UPTAKE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; ISOTOPE LABELING; MALE; MASS SPECTROMETRY; MOUSE; MYELOOPTIC NEUROPATHY; NONHUMAN; PRIORITY JOURNAL;

AMEBICIDES; ANIMALS; BRAIN; CLIOQUINOL; MALE; METALS; MICE; MICE, INBRED STRAINS; OPTIC NERVE DISEASES; S-ADENOSYLHOMOCYSTEINE; S-ADENOSYLMETHIONINE; TRACE ELEMENTS; VITAMIN B 12;

EID: 0033974529     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-510X(99)00297-X     Document Type: Article

References (20)

1. Ohtsuka K., Ohishi N., Eguchi G., Yagi K. Degeneration of retinal neuroblasts by chinoform-ferric chelate. Experientia. 38:(1):1982;120-122.
2. Tjälve H., Ståhl K. Effect of 5-chloro-7-iodo-8-hydroxy-quinoline (Clioquinol) on the uptake and distribution of nickel, zinc and mercury in mice. Acta Pharmacol Toxicol. 55:1984;65-72.
3. 12 levels in cerebrospinal fluid in patients with a variety of neurological disorders. J Nutr Sci Vitaminol. 23:1977;299-304.
4. Prasad K. Homocysteine, a risk factor for cardiovascular disease. Int J Angiol. 8:1999;76-86.
5. Bottiglieri T., Hyland K. S-adenosylmethionine levels in psychiatric and neurological disorders: a review. Acta Neurol Scand. 89:(suppl 154):1994;19-26.
6. Rodushkin I., Ruth T. Determination of trace metals in estuarine and sea-water reference materials by high resolution inductively coupled plasma mass spectrometry. J Anal Atomic Spectrom. 12:1997;1181-1185.
7. 12: Effects of clioquinol treatment in mice. Jpn J Pharmacol. 78:1998;55-61.
8. Kosaka K., Arai H., Kobayashi K., Inada M. Changes of methylcobalamin in Alzheimer-type dementia brains. Dementia. 3:1989;219-222.
9. Inada M., Toyoshima B., Kameyama M. Cobalamin contents of the brain in some clinical and pathological states. Int J Vit Nutr Res. 52:1982;423-429.
10. Whetsell W.O. Jr. Current concepts of excitotoxicity. J Neuropathol Exp Neurol. 55:(1):1996;1-13.
11. 12 deficiency in dementia disorders. Dosert P., Riederer L., Strolin Benedetti M., Ronrucci R. Early markers in Parkinson's and Alzheimer's diseases. vol. I:1990;267-286 Springer, Wein.
12. Do K.Q., Herrling P.L., Streit P., Cuenod M. Release of neuroactive substances: homocystenic acid as an endogeneous agonist of the NMDA receptor. J Neural Transm. 72:1988;185-190.
13. Robinson M.B., Coyle J.T. Glutamate and related acidic excitatory neurotransmitters: from basic science to clinical application. FASEB J. 1:1987;446-455.
14. 12 on brain methionine adenosyltransferase activity in senile dementia of the Alzheimer's type. J Neural Transm. 103:(7):1996;861-872.
15. Gomes-Trolin C., Regland B., Oreland L. Decreased methionine adenosyltransferase activity in erythrocytes of patients with dementia disorders. Eur Neuopsychopharmacol. 5:(2):1995;107-114.
16. 12 homeostasis. Proc Natl Acad Sci USA. 93:1996;8612-8617.
17. Gibbons R.A., Dixon S.N., Hallis K., Russell A.M., Sansom B.F., Symonds H.W. Manganese metabolism in cows and goats. Biochim Biophys Acta. 444:1976;1-10.
18. Butt E.M., Nusbaum R.E., Gilmour T.C., Didio S.L., Sister M. Trace metal levels in human serum and blood. Arch Environ Health. 8:1964;52-57.
19. Cheng H., Gomes-Trolin C., Aquilonius S.M., Löfberg C., Ekblom J., Oreland L. Levels of L-methionine S-adenosyltransferase activity in erythrocytes and concentrations of S-adenosylmethionine and S-adenosylhomocysteine in whole blood of patients with Parkinson's disease. Exp Neurol. 145:1997;580-585.
20. Gomes-Trolin C., Yassin M.S., Gottfries C.G., Regland B., Grenfeldt B., Hallman J., Prince J., Oreland L. Erythrocyte and brain methionine adenosyltransferase activities in patients with schizophrenia. J Neural Transm. 150:1998;1293-1305.